What was FEM-PrEP?
Publications
Early Closure Fact Sheets

Investigators, staff, and collaborators
Contact Information
Related Research & Information

Perception of HIV risk and adherence to a daily, investigational product for HIV prevention in FEM-PrEP

PubMed

Publications

Tenofovir diphosphate and emtricitabine triphosphate concentrations in blood cells compared with isolated peripheral blood mononuclear cells: A new measure of antiretroviral adherence?
Adherence in FEM-PrEP: Participants’ explanations for taking the investigational pre-exposure prophylaxis pill for HIV prevention
Intermittent behavioral risk reduction as a realistic scenario for potential pre-exposure prophylaxis (PrEP) users: A qualitative study among high-risk women in Bondo, Kenya

Related Research & Information

FHI 360 and others are currently or have recently conducted complimentary research on ARV-based HIV prevention products.
Read more